Plasma P-tau2017 and Quantitative Amyloid PET Imaging

Status:
Recruiting

Trial end date:
2022-09-01

Target enrollment:

Participant gender:

The overall goal of this protocol is to compare amyloid burden assessed by amyloid PET to plasma P-tau217 levels.

Phase 1

Invicro